Ffolliott Martin Fisher

Title: Ffolliott Martin Fisher: Innovator in Fructose Metabolism Research

Introduction

Ffolliott Martin Fisher is a notable inventor based in Watertown, MA (US). He has made significant contributions to the field of metabolism research, particularly in understanding fructose metabolism. His innovative work has led to the development of a patent that addresses important health issues related to fructose intake.

Latest Patents

Fisher holds a patent for the invention titled "Measurement of FGF21 as a biomarker of fructose metabolism." This invention provides methods for monitoring the fructose response of a subject by determining the level of fibroblast growth factor 21 (FGF21) gene expression product in a biological sample, such as serum. The methods outlined in the patent are designed to help in various applications, including monitoring responses to treatments for metabolic disorders and identifying subjects at risk for developing such disorders.

Career Highlights

Ffolliott Martin Fisher is affiliated with Beth Israel Deaconess Medical Center, Inc., where he continues to advance research in metabolic health. His work is crucial in the ongoing efforts to understand and treat disorders related to fructose metabolism.

Collaborations

Fisher collaborates with esteemed colleagues, including Eleftheria Maratos-Flier and Mark A Herman. These partnerships enhance the research and development of innovative solutions in the field of metabolism.

Conclusion

Ffolliott Martin Fisher's contributions to the understanding of fructose metabolism through his patented methods highlight his role as an important inventor in the medical research community. His work not only advances scientific knowledge but also has the potential to improve health outcomes for individuals with metabolic disorders.